Tag: Mesothelioma News

In early 2023, the world-class Hospital of the University of Pennsylvania will open a groundbreaking clinical trial for mesothelioma patients utilizing a next-generation immunotherapy with a novel delivery platform. The U.S. Food and Drug Administration cleared the path in September by granting orphan drug designation for SynKIR-110, a CAR T-cell therapy designed to target solid […]

The post Orphan Drug Designation Given to New Mesothelioma CAR T-Cell Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

No one is immune to the effects of toxic asbestos fibers, the primary cause of mesothelioma cancer. Not even horses. Although mesothelioma is a rare cancer in humans, it is even more rare in animals, particularly horses that spend most of their time grazing outdoors. But it still happens. Both pleural mesothelioma and peritoneal mesothelioma […]

The post Rare Mesothelioma Cancer Discovered in Quarter Horse appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Johnson & Johnson’s controversial bankruptcy filing, designed to limit its soaring talc liabilities, was challenged Sept. 26 before the United States Court of Appeals for the Third Circuit in Philadelphia. A three-judge panel heard oral arguments on whether Johnson & Johnson should be permitted to shift billions of dollars in mass tort liabilities to a […]

The post U.S. Court of Appeals Hears Challenge to J&J’s Bankruptcy Plan appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.